论文部分内容阅读
由中国疾控中心性病艾滋病预防控制中心与深圳匹基公司组成的 SARS 核酸诊断试剂研制联合攻关组已完成了 SARS 核酸诊断试剂的研制工作。在经过国家食品和药品监督管理局的严格评审后,成为我国批准的第一个 SARS 核酸诊断试剂。通过对临床样品的考核,所研制的 SARS 核酸诊断试剂用于SARS 临床确诊病例检测的敏感性较高,最早可在 SARS 病人发热的当天检测到 SARS 病毒;其检测特异性为100％,在与世界上第一个批准的德国 ARTUS 公司的 SARS 病毒核酸荧光检测试剂对比中发现,两者
SARS Nucleic Acid Diagnostic Reagent Research and Development Joint Research Group consisting of STD and AIDS prevention and control center of China Center for Disease Control and Prevention and Shenzhen Pickey Company has completed the research and development of SARS nucleic acid diagnostic reagents. After the strict assessment by the State Food and Drug Administration, China became the first SARS nucleic acid diagnostic reagent approved. Through the examination of clinical samples, the developed SARS nucleic acid diagnostic reagent has high sensitivity for detecting clinically confirmed cases of SARS and can detect the SARS virus as early as the day of fever on the SARS patient. The detection specificity is 100% The world’s first approved ARTUS company in Germany SARS virus nucleic acid fluorescence detection reagent comparison found that both